Circulating tumor DNA dynamics on front line chemotherapy with bevacizumab or cetuximab in metastatic colorectal cancer: a biomarker analysis for acquired genomic alterations in CALGB/SWOG 80405 (Alliance) randomized trial
- Citation:
- J Clin Oncol vol 40 (4_suppl) abstr 193
- Meeting Instance:
- ASCO GI 2022
- Year:
- 2022
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3694
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- Pharmas:
- Grants:
- R01 CA184843; U10 CA180821; U1 0CA180888
- Corr. Author:
- Authors:
- Kanwal Raghav Fang-Shu Ou Alan P Venook Federico Innocenti Ryan Sun Heinz-Josef Lenz Scott Kopetz
- Networks:
- CA011, CA136, LAPS-MN026, LAPS-NC007, LAPS-TX035
- Study
- CALGB-80405
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: